Evidence map›Paper›PMID 34021055›Full record

ArticleNeurology(R) neuroimmunology & neuroinflammation2021

Network Damage Predicts Clinical Worsening in Multiple Sclerosis: A 6.4-Year Study.

Maria A Rocca, Paola Valsasina, Alessandro Meani, Elisabetta Pagani, Claudio Cordani, Chiara Cervellin, Massimo Filippi

Open access · goldAbstract read
In one paragraph

Article in Neurology(R) neuroimmunology & neuroinflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression.Neurology(R) neuroimmunology & neuroinflammation · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Maria A RoccaFrom the Neuroimaging Research Unit (M.A.R.), Division of Neuroscience; and Neurology Unit, IRCCS San Raffaele Scientific Institute; Vita-Salute San Raffaele University (M.A.R., M.F.); Neuroimaging Research Unit (P.V., A.M., E.P., Claudio Cordani, Chiara Cervellin), Division of Neuroscience, IRCCS San Raffaele Scientific Institute; and Neuroimaging Research Unit (M.F.), Division of Neuroscience, Neurology Unit, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0003-2358-4320
Paola ValsasinaFrom the Neuroimaging Research Unit (M.A.R.), Division of Neuroscience; and Neurology Unit, IRCCS San Raffaele Scientific Institute; Vita-Salute San Raffaele University (M.A.R., M.F.); Neuroimaging Research Unit (P.V., A.M., E.P., Claudio Cordani, Chiara Cervellin), Division of Neuroscience, IRCCS San Raffaele Scientific Institute; and Neuroimaging Research Unit (M.F.), Division of Neuroscience, Neurology Unit, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Alessandro MeaniFrom the Neuroimaging Research Unit (M.A.R.), Division of Neuroscience; and Neurology Unit, IRCCS San Raffaele Scientific Institute; Vita-Salute San Raffaele University (M.A.R., M.F.); Neuroimaging Research Unit (P.V., A.M., E.P., Claudio Cordani, Chiara Cervellin), Division of Neuroscience, IRCCS San Raffaele Scientific Institute; and Neuroimaging Research Unit (M.F.), Division of Neuroscience, Neurology Unit, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Elisabetta PaganiFrom the Neuroimaging Research Unit (M.A.R.), Division of Neuroscience; and Neurology Unit, IRCCS San Raffaele Scientific Institute; Vita-Salute San Raffaele University (M.A.R., M.F.); Neuroimaging Research Unit (P.V., A.M., E.P., Claudio Cordani, Chiara Cervellin), Division of Neuroscience, IRCCS San Raffaele Scientific Institute; and Neuroimaging Research Unit (M.F.), Division of Neuroscience, Neurology Unit, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Claudio CordaniFrom the Neuroimaging Research Unit (M.A.R.), Division of Neuroscience; and Neurology Unit, IRCCS San Raffaele Scientific Institute; Vita-Salute San Raffaele University (M.A.R., M.F.); Neuroimaging Research Unit (P.V., A.M., E.P., Claudio Cordani, Chiara Cervellin), Division of Neuroscience, IRCCS San Raffaele Scientific Institute; and Neuroimaging Research Unit (M.F.), Division of Neuroscience, Neurology Unit, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Chiara CervellinFrom the Neuroimaging Research Unit (M.A.R.), Division of Neuroscience; and Neurology Unit, IRCCS San Raffaele Scientific Institute; Vita-Salute San Raffaele University (M.A.R., M.F.); Neuroimaging Research Unit (P.V., A.M., E.P., Claudio Cordani, Chiara Cervellin), Division of Neuroscience, IRCCS San Raffaele Scientific Institute; and Neuroimaging Research Unit (M.F.), Division of Neuroscience, Neurology Unit, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Massimo FilippiFrom the Neuroimaging Research Unit (M.A.R.), Division of Neuroscience; and Neurology Unit, IRCCS San Raffaele Scientific Institute; Vita-Salute San Raffaele University (M.A.R., M.F.); Neuroimaging Research Unit (P.V., A.M., E.P., Claudio Cordani, Chiara Cervellin), Division of Neuroscience, IRCCS San Raffaele Scientific Institute; and Neuroimaging Research Unit (M.F.), Division of Neuroscience, Neurology Unit, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.ORCID 0000-0002-5485-0479
Vita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn multiple sclerosis (MS), clinical impairment is likely due to both structural damage and abnormal brain function. We assessed the added value of integrating structural and functional network MRI measures to predict 6.4-year MS clinical disability deterioration.

methodsBaseline 3D T1-weighted and resting-state functional MRI scans were obtained from 233 patients with MS and 77 healthy controls. Patients underwent a neurologic evaluation at baseline and at 6.4-year median follow-up (interquartile range = 5.06-7.51 years). At follow-up, patients were classified as clinically stable/worsened according to disability changes. In relapsing-remitting (RR) MS, secondary progressive (SP) MS conversion was evaluated. Global brain volumetry was obtained. Furthermore, independent component analysis identified the main functional connectivity (FC) and gray matter (GM) network patterns.

resultsAt follow-up, 105/233 (45%) patients were clinically worsened; 26/157 (16%) patients with RRMS evolved to SPMS. The treatment-adjusted random forest model identified normalized GM and brain volumes, decreased FC between default-mode networks, increased FC of the left precentral gyrus in the sensorimotor network (SMN), and GM atrophy in the fronto-parietal network (false discovery rate [FDR]-corrected

conclusionsIntegration of MRI network measures helped determining the relative contributions of global/local GM damage and functional reorganization to clinical deterioration in MS.

Indexed as

ConnectomeDisease ProgressionGray MatterMultiple Sclerosis, Chronic ProgressiveMultiple Sclerosis, Relapsing-RemittingNerve NetAdultFemaleFollow-Up StudiesHumansMagnetic Resonance ImagingMaleMiddle AgedPrognosis

Identifiers

PMID34021055
PMCPMC8143700
OpenAlexW3160814547

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.